Enclomiphene and Tadalafil for Low Testosterone and ED
Learn how enclomiphene affects testosterone and sperm counts, how tadalafil and vardenafil differ, and what to ask about low testosterone and ED.

Enclomiphene can raise testosterone and maintain sperm concentration in some men with secondary hypogonadism, based on short clinical trials. Tadalafil and vardenafil treat erectile dysfunction through a different pathway. Their U.S. prescribing labels advise against combining them. Start by discussing symptoms, repeat morning labs, medications, and fertility goals with a physician.

How does enclomiphene compare with TRT?
Testosterone replacement therapy supplies testosterone from outside the body and can suppress the signals needed for sperm production. Enclomiphene stimulates those signals, which may help certain men with secondary hypogonadism. Trial results support a short-term effect on serum testosterone and sperm concentration. They do not establish pregnancy outcomes or long-term safety.
Enclomiphene is a selective estrogen receptor modulator, or SERM. It reduces estrogen feedback at the hypothalamus and pituitary, increasing luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH signals the testes to make testosterone. FSH, together with testosterone within the testes, supports sperm production. External testosterone can reduce LH and FSH through feedback, suppressing sperm production. [1–4]
In two 16-week phase 3 studies in overweight men aged 18–60 with secondary hypogonadism, enclomiphene raised testosterone into the normal range and increased LH and FSH while maintaining sperm concentration. Testosterone gel also raised serum testosterone, while LH, FSH and sperm production declined. An earlier randomized phase 2 study reported a similar pattern. [2, 3]
One six-week study measured testosterone and LH increases. Lab response can emerge over weeks, while the time to symptom relief remains uncertain. Sperm concentrations in a trial cannot predict an individual’s chance of conception, testicular size, or return to baseline after stopping. Enclomiphene lacks FDA approval, and regulators have identified potential safety concerns, including blood clots. [2–5]
What does tadalafil do for erectile dysfunction?
Tadalafil helps men with erectile dysfunction get and maintain an erection when sexually stimulated. The as-needed form can work on the day it is taken, while testosterone changes with enclomiphene were measured over weeks. Small tadalafil studies found changes in blood vessel markers and lean mass. These findings are preliminary.
During sexual stimulation, nitric oxide promotes production of cyclic guanosine monophosphate (cGMP). Tadalafil blocks phosphodiesterase type 5 (PDE5), the enzyme that breaks down cGMP. This helps smooth muscle relax and increases blood flow into the penis. Vardenafil works through the same pathway. [6, 7]
A 20-person pilot study found changes in markers of endothelial function, which reflect how blood vessels respond. In a two-month study of 43 non-obese men with mild ED and/or lower urinary tract symptoms, daily tadalafil was associated with gains in lean mass and changes in endothelial markers. Neither study establishes benefits for focus, exercise recovery, endurance or metabolic health, or for a regimen combining tadalafil with enclomiphene. [8, 9]
How do tadalafil and vardenafil compare?
Tadalafil lasts longer and has both daily and as-needed options for erectile dysfunction. Vardenafil is a shorter-acting, as-needed alternative. Separate half-lives do not make overlapping treatment safe. The prescribing labels advise against combining these drugs, and taking both can increase the risk of an unsafe drop in blood pressure.
| ED medication | Labeled use for ED | Timing and duration |
|---|---|---|
| Tadalafil | Once daily or as needed | As-needed benefit shown up to 36 hours. Terminal half-life is about 17.5 hours. [6] |
| Vardenafil | As needed | Label advises taking it about 60 minutes before sexual activity. Terminal half-life is about 4–5 hours. [7] |
What should I discuss before starting treatment?
Bring your symptoms, medications, recent labs and plans for having children to the visit. A physician can confirm whether testosterone is consistently low, look for the cause, and assess erectile dysfunction separately. If treatment is appropriate, ask how you will track both symptoms and lab changes over time.
1. Confirm the diagnosis. Low libido, fatigue, poor focus and inconsistent erections can have different causes. Clinicians look for compatible symptoms and consistently low testosterone on two separate early-morning tests. LH and FSH help distinguish secondary hypogonadism from a problem in the testes. Prolactin or free testosterone may be appropriate depending on the findings. [1, 10]
2. Clarify fertility goals. Tell your physician if you are trying to conceive now or want children later. Ask whether a semen analysis or reproductive urology referral makes sense. Guidelines advise against starting testosterone therapy when near-term fertility is a goal. [1, 10]
3. Check ED risks and medication interactions. New or persistent ED can be a sign of cardiovascular disease. Both medicines are contraindicated with nitrates or guanylate cyclase stimulators such as riociguat. Alpha blockers and certain other medicines can affect safety. Vardenafil also carries a QT warning for people with congenital long QT syndrome or those taking certain antiarrhythmics. Seek urgent care for an erection lasting more than four hours or any sudden loss of vision or hearing. [6, 7, 11]
4. Agree on a follow-up plan. If a physician prescribes treatment, ask what changes to track, when to repeat labs and what side effects to report. Bring up patterns such as post-workout fatigue or late-day brain fog so your physician can evaluate them directly. These symptoms alone are not indications for tadalafil or vardenafil. [1, 6, 7, 11]

Common questions about PEPLIX HEALTH
Peplix Health is a cash-pay telehealth service managed by Monarch Brands LLC. An independent, board-certified physician evaluates whether treatment is appropriate and individualizes the prescription and follow-up when indicated. A state-licensed pharmacy can fulfill a patient-specific compounded prescription when applicable Section 503A and state requirements are met.
Can I take tadalafil and vardenafil together?
The U.S. prescribing labels advise against overlap. If tadalafil is not working well or the timing is inconvenient, ask your physician about switching and how to avoid overlap. [6, 7]
Can a physician address low testosterone and ED at the same visit?
Yes. Testosterone testing helps identify a hormone problem, and a separate ED assessment guides treatment for erections. Evidence that either drug works for its own target does not establish that enclomiphene and tadalafil work better as a pair. [1–6, 11]
Can enclomiphene help preserve fertility if I have low testosterone?
Trials in men with secondary hypogonadism showed that sperm concentration was maintained during treatment. Pregnancy and live-birth benefits remain unproven. Tell your physician about your fertility goals before starting any hormonal treatment. [1–3, 10]
How soon might I notice changes with enclomiphene or tadalafil?
Tadalafil can improve erections the day it is taken as needed. A six-week enclomiphene study measured changes in testosterone and LH, and later trials tracked hormones and sperm concentration over 16 weeks. A change in a lab result does not predict when energy, libido or ED will improve. [2–4, 6]
Is enclomiphene FDA approved and how does 503A fulfillment work?
Enclomiphene is not FDA approved. Compounded medicines are also not FDA approved and do not undergo FDA premarket review for safety, effectiveness or quality. Section 503A pharmacy fulfillment depends on a valid prescription for an identified patient, eligibility of the specific preparation and applicable federal and state rules. Discuss the reason for compounding and the dispensing pharmacy with your care team. [5, 12, 13]
How do I prepare for a Peplix Health visit?
Have your medication list, recent labs and questions about fertility or erectile function ready. For information about consultations, see our low testosterone guide or start an online assessment.
Medical information notice. This article is for education. Discuss diagnosis, medication changes and treatment risks with a licensed healthcare professional.
Sources
- Endocrine Society. Clinical practice guideline on testosterone therapy (2018).
- Wiehle et al. Randomized phase 2 enclomiphene and testosterone gel trial (2014).
- Kim et al. Phase 3 enclomiphene studies in men with secondary hypogonadism (2016).
- Wiehle et al. Six-week enclomiphene pharmacodynamics study.
- FDA. Enclomiphene citrate advisory committee briefing (2022).
- DailyMed. U.S. prescribing information for Cialis (tadalafil).
- DailyMed. U.S. prescribing information for vardenafil hydrochloride tablets.
- Rosano et al. Tadalafil and endothelial function pilot study (2007).
- Aversa et al. Tadalafil, lean mass and endothelial markers (2017).
- AUA and ASRM. Male infertility guideline, amended 2024.
- AUA. Erectile dysfunction guideline.
- FDA. Compounding questions and answers.
- FDA. Prescription requirements under Section 503A.


